GKAP activators comprise a diverse array of chemical compounds specifically chosen for their ability to indirectly augment the functional activity of GKAP within neuronal synapses. Forskolin and 8-Br-cAMP are such activators that raise levels of cAMP, a critical second messenger in neurons, leading to the activation of protein kinase A (PKA). PKA then phosphorylates various synaptic proteins, which can enhance the interactions and scaffolding functions of GKAP within the post-synaptic density. Similarly, Ionomycin, by increasing intracellular calcium, may facilitate GKAP's role in synaptic signaling pathways dependent on calcium fluxes. On the other hand, the application of Tetrodotoxin serves to modulate neuronal activity by blocking sodium channels, which could lead to a compensatory upregulation of synaptic protein interactions, thereby enhancing GKAP's activity. PMA, which activates PKC, and Okadaic acid, an inhibitor of protein phosphatases, both lead to altered phosphorylation states of proteins in the synaptic milieu, potentially strengthening GKAP's scaffolding interactions and signaling functions.
Furthermore, compounds like BAPTA-AM, Anisomycin, Kainic acid, CNQX, Nimodipine, and Ryanodine all contribute to fine-tuning the synaptic environment in which GKAP operates. BAPTA-AM, by chelating calcium, and Nimodipine, by blocking L-type calcium channels, indirectly modulate the calcium-dependent processes that GKAP may be involved in. Anisomycin, while inhibiting protein synthesis, could shift the synaptic protein landscape in a way that favors GKAP activity. Excitatory stimulation through Kainic acid or modulation of synaptic transmission via CNQX can lead to enhanced GKAP function due to their effects on glutamater.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises intracellular cAMP levels, which in turn activates PKA. PKA phosphorylation can enhance GKAP interactions with other synaptic proteins. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $106.00 $166.00 $289.00 $550.00 $819.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate acts as a cAMP analog, activating PKA and subsequently enhancing GKAP binding to its associated proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, indirectly enhancing GKAP's scaffolding functions at synaptic sites. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate substrates that interact with GKAP, enhancing its synaptic functions. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
BAPTA-AM chelates intracellular calcium, which can indirectly modulate signaling pathways involving GKAP through calcium-dependent processes. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid inhibits protein phosphatases 1 and 2A, altering the phosphorylation state of proteins that may associate with GKAP, enhancing its activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin acts as a protein synthesis inhibitor, potentially altering the synaptic protein composition and indirectly enhancing GKAP's role in synapses. | ||||||
Kainic acid | 487-79-6 | sc-200454 sc-200454A sc-200454B sc-200454C sc-200454D | 5 mg 25 mg 100 mg 1 g 5 g | $85.00 $370.00 $1350.00 $7650.00 $24480.00 | 12 | |
Kainic acid stimulates glutamate receptors, which may intensify GKAP-mediated signaling by potentiating synaptic transmission. | ||||||
6-Cyano-7-nitroquinoxaline-2,3-dione | 115066-14-3 | sc-505104 | 10 mg | $204.00 | 2 | |
CNQX is an AMPA receptor antagonist, which can alter synaptic activity and potentially enhance GKAP-mediated postsynaptic density signaling. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $60.00 $301.00 | 2 | |
Nimodipine blocks L-type calcium channels, possibly leading to alterations in neuronal signaling that indirectly enhance the role of GKAP in the synapse. | ||||||